← Open Payments lookup

MEEGAN CHESTNUT: Open Payments

NPI 1255513636 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$462 in 21 payments from 8 companies in 2025. Trend: 2023 $488 · 2024 $789 · 2025 $462

Food & beverage: $462
CompanyPaymentsAmount
Novo Nordisk Inc11$233
Lilly USA, LLC3$68
AstraZeneca Pharmaceuticals LP2$47
Bayer Healthcare Pharmaceuticals Inc.1$30
Hologic Sales and Service, LLC1$29
Esperion Therapeutics, Inc.1$22
Currax Pharmaceuticals LLC1$17
Abbott Laboratories1$15

Products named: Ozempic, Rybelsus, Wegovy, MOUNJARO, AIRSUPRA, Kerendia, APTIMA, NEXLETOL.

Industry payments across MD — which companies pay providers there.